Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA
The treatment or prevention of bleeding in patients with hemophilia A relies on replacement therapy with different factor VIII (FVIII)-containing products or on the use of by-passing agents, i.e., activated prothrombin complex concentrates or recombinant activated factor VII. Emerging approaches inc...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ferrata Storti Foundation
2020-04-01
|
| coleção: | Haematologica |
| Acesso em linha: | https://haematologica.org/article/view/9347 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|